EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:753629 - tildrakizumab
| ChEBI ID | CHEBI:753629 |
| ChEBI Name | tildrakizumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | chembl-etl |
| Roles Classification |
|---|
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antipsoriatic A drug used to treat psoriasis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| tildrakizumab (CHEBI:753629) has role antineoplastic agent (CHEBI:35610) |
| tildrakizumab (CHEBI:753629) has role antipsoriatic (CHEBI:50748) |
| tildrakizumab (CHEBI:753629) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| MK-3222 | ChEMBL |
| SCH-900222 | ChEMBL |
| Tildrakizumab | ChEMBL |
| Tildrakizumab asmn | ChEMBL |
| Tildrakizumab-asmn | ChEMBL |
| Brand Names | Source |
|---|---|
| Ilumetri | ChEMBL |
| Ilumya | ChEMBL |